Skip to content

Clinical trials

Phase 2 Angina Pectoris trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angina Pectoris Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20051
20061
20071
20091
20122
20141
20152
20202
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lisata Therapeutics, Inc.2
North Florida Foundation for Research and Education2
Amgen1
Celgene1
Corautus Genetics1
Corewell Health East1
Imbria Pharmaceuticals, Inc.1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angina Pectoris15
Coronary Artery Disease3
Myocardial Ischemia3
Cardiovascular Diseases2
Chest Pain2
Angina, Stable1
Atherosclerosis1
Coronary Disease1
Heart Failure1
Inflammation1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.